← back to search

Yuan Liu

Guangdong Pharmaceutical University · CN
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Renal cell carcinoma treatment, Pancreatic and Hepatic Oncology Research, Cancer Immunotherapy and Biomarkers, and Lung Cancer Treatments and Mutations.
h-index
32
citations
3,349
works
302
NIH funding
primary concept
email

Recent publications

Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial
Nature Cancer 2025cited by 11position: middledoi
Association of baseline inflammatory biomarkers and clinical outcomes in patients with advanced renal cell carcinoma treated with immune checkpoint inhibitors
Therapeutic Advances in Medical Oncology 2025cited by 7position: middledoi
Physician Assessment of ChatGPT and Bing Answers to American Cancer Society’s Questions to Ask About Your Cancer
American Journal of Clinical Oncology 2023cited by 26position: middledoi
ZANUBRUTINIB (ZANU) VERSUS BENDAMUSTINE + RITUXIMAB (BR) IN PATIENTS (PTS) WITH TREATMENT‐NAïVE (TN) CLL/SLL: EXTENDED FOLLOW‐UP OF THE SEQUOIA STUDY
Hematological Oncology 2023cited by 13position: middledoi
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinoma
Nature Communications 2022cited by 34position: middledoi
Baseline basophil and basophil-to-lymphocyte status is associated with clinical outcomes in metastatic hormone sensitive prostate cancer
Urologic Oncology Seminars and Original Investigations 2022cited by 24position: middledoi
Immune-Related Adverse Events as Clinical Biomarkers in Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
The Oncologist 2021cited by 41position: middledoi
Body Composition Variables as Radiographic Biomarkers of Clinical Outcomes in Metastatic Renal Cell Carcinoma Patients Receiving Immune Checkpoint Inhibitors
Frontiers in Oncology 2021cited by 35position: middledoi
Body Composition as an Independent Predictive and Prognostic Biomarker in Advanced Urothelial Carcinoma Patients Treated with Immune Checkpoint Inhibitors
The Oncologist 2021cited by 32position: middledoi
Modified Glasgow Prognostic Score associated with survival in metastatic renal cell carcinoma treated with immune checkpoint inhibitors
Journal for ImmunoTherapy of Cancer 2021cited by 29position: middledoi
Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors
The Oncologist 2021cited by 29position: middledoi
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody
American Journal of Clinical Oncology 2020cited by 64position: middledoi
Detection of crown-like structures in breast adipose tissue and clinical outcomes among African-American and White women with breast cancer
Breast Cancer Research 2020cited by 35position: middledoi
Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study
Journal of Surgical Research 2020cited by 26position: middledoi
Triple‐negative apocrine carcinoma: A rare pathologic subtype with a better prognosis than other triple‐negative breast cancers
Journal of Surgical Oncology 2020cited by 24position: middledoi
Carrying out streamlined routine data analyses with reports for observational studies: introduction to a series of generic SAS® macros
F1000Research 2019cited by 73position: firstdoi
Combined Effect of Sarcopenia and Systemic Inflammation on Survival in Patients with Advanced Stage Cancer Treated with Immunotherapy
The Oncologist 2019cited by 63position: middledoi
Novel Risk Scoring System for Patients with Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors
The Oncologist 2019cited by 38position: middledoi
The impact of unplanned excisions of truncal/extremity soft tissue sarcomas: A multi‐institutional propensity score analysis from the US Sarcoma Collaborative
Journal of Surgical Oncology 2019cited by 35position: middledoi
Skin lightening practices, beliefs, and self-reported adverse effects among female health science students in Borama, Somaliland: A cross-sectional survey
International Journal of Women’s Dermatology 2019cited by 33position: middledoi
Proton vs. Photon Radiation Therapy for Primary Gliomas: An Analysis of the National Cancer Data Base
Frontiers in Oncology 2018cited by 49position: middledoi
Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma
American Journal of Neuroradiology 2017cited by 65position: middledoi
Is less more? Comparing chemotherapy alone with chemotherapy and radiation for high‐risk grade 2 glioma: An analysis of the National Cancer Data Base
Cancer 2017cited by 32position: middledoi
National Cancer Database Analysis of Proton Versus Photon Radiation Therapy in Non-Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics 2016cited by 124position: middledoi
Nodal Upstaging Is More Common with Thoracotomy than with VATS During Lobectomy for Early-Stage Lung Cancer: An Analysis from the National Cancer Data Base
Journal of Thoracic Oncology 2016cited by 120position: middledoi
Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy
International Journal of Radiation Oncology*Biology*Physics 2016cited by 102position: middledoi
Pulmonary Sarcomatoid Carcinoma: An Analysis of the National Cancer Data Base
Clinical Lung Cancer 2016cited by 92position: middledoi
Socioeconomic Factors Are Associated With Readmission After Lobectomy for Early Stage Lung Cancer
The Annals of Thoracic Surgery 2016cited by 63position: middledoi
The role of adjuvant radiotherapy in pathologically lymph node‐positive prostate cancer
Cancer 2016cited by 62position: middledoi
Evaluating Intensity-Modulated Radiation Therapy in Locally Advanced Non–Small-Cell Lung Cancer: Results From the National Cancer Data Base
Clinical Lung Cancer 2016cited by 47position: middledoi

Grants

Travel: Student Travel Support for Workshop on Quantum Signal Processing during IEEE Quantum Week 2026
NSF2623250$35,0002026–2027PIRePORTER
LEAPS-MPS: Robust and High Order Numerical Simulation for Phase Field Modeling
NSF2213436$250,0002022–2025PIRePORTER
Galois Structures and Arithmetic Statistics
NSF2200541$141,4002022–2026PIRePORTER
Boron-Nitrogen-Doped Conjugated Aromatic Hydrocarbons
NSF1561153$380,0002016–2019PIRePORTER
Novel Polypyridine Ligands: Synthesis, Characterization, and Applications
NSF1361618$241,9992013–2016PIRePORTER
Novel Polypyridine Ligands: Synthesis, Characterization, and Applications
NSF1212346$252,9472012–2014PIRePORTER

Frequent collaborators

Theresa Gillespie · Emory University13 papers (2014–2020)Mehmet Asım Bilen · Emory Healthcare10 papers (2019–2025)Bradley Curtis Carthon · Emory University9 papers (2019–2025)Ömer Küçük · Emory University9 papers (2016–2025)Viraj A. Master · Emory University9 papers (2016–2025)Dylan J. Martini · Massachusetts General Hospital8 papers (2019–2021)Haydn Kissick · Emory University8 papers (2019–2022)Jacqueline T. Brown · Emory University8 papers (2019–2025)Sarah Caulfield · Emory Healthcare8 papers (2019–2025)Walter J. Curran · Piedmont Atlanta Hospital7 papers (2014–2018)Greta Russler · Emory University7 papers (2019–2022)Wayne Harris · Emory University7 papers (2019–2025)Dana Nickleach · AmerisourceBergen (United States)6 papers (2014–2019)Lauren Yantorni · Emory University6 papers (2021–2022)Félix G. Fernández · Emory Healthcare6 papers (2014–2016)Bassel Nazha · Emory University6 papers (2021–2025)Suresh S. Ramalingam · Emory University6 papers (2014–2019)Julie M. Shabto · Hara Eye Hospital5 papers (2019–2021)Kristin Higgins · City Of Hope National Medical Center5 papers (2014–2016)Kirtesh R. Patel · University College London Hospitals NHS Foundation Trust5 papers (2014–2018)